Seeking Alpha

CLDN
  Celladon Corporation - NASDAQ

10/22/2014, 2:44 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
CLDN vs. ETF Alternatives
Company Description
Celladon Corp is a clinical-stage biotechnology company. The Company is engaged in developing treatments for heart failure, diabetes and neurodegenerative diseases.
Sector: Healthcare
Industry: Biotechnology
Country: United States